Crossmark Global Holdings, Inc. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 254 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$262
-14.9%
2,581
-0.5%
0.01%
-14.3%
Q2 2023$308
-2.8%
2,595
-15.0%
0.01%0.0%
Q1 2023$317
+39.6%
3,054
+19.1%
0.01%
+16.7%
Q4 2022$227
-99.9%
2,564
-6.8%
0.01%0.0%
Q3 2022$221,000
-16.0%
2,750
+0.4%
0.01%
-14.3%
Q2 2022$263,000
-36.8%
2,740
-2.1%
0.01%
-22.2%
Q1 2022$416,000
+7.8%
2,800
+2.9%
0.01%
+12.5%
Q4 2021$386,000
+18.0%
2,720
+8.8%
0.01%0.0%
Q3 2021$327,000
-7.9%
2,500
-3.1%
0.01%0.0%
Q2 2021$355,000
+1.4%
2,580
-3.7%
0.01%
-11.1%
Q1 2021$350,000
+12.2%
2,680
-3.9%
0.01%
+12.5%
Q4 2020$312,000
-4.6%
2,790
-32.9%
0.01%
-11.1%
Q3 2020$327,000
+3.8%
4,160
-5.0%
0.01%0.0%
Q2 2020$315,000
+36.4%
4,380
+8.4%
0.01%
+12.5%
Q1 2020$231,000
-49.3%
4,040
-1.0%
0.01%
-38.5%
Q4 2019$456,000
-28.0%
4,080
-38.0%
0.01%
-27.8%
Q3 2019$633,000
+9.7%
6,580
-2.4%
0.02%
+12.5%
Q2 2019$577,000
-4.6%
6,740
-7.4%
0.02%
-5.9%
Q1 2019$605,000
+34.4%
7,276
+3.9%
0.02%
+21.4%
Q4 2018$450,000
+25.3%
7,006
+54.8%
0.01%
+55.6%
Q3 2018$359,000
+13.2%
4,526
+4.4%
0.01%0.0%
Q2 2018$317,000
+18.3%
4,336
+2.4%
0.01%
+28.6%
Q1 2018$268,0000.0%4,236
-19.3%
0.01%
+16.7%
Q4 2017$268,000
-4.6%
5,252
-1.9%
0.01%
-14.3%
Q3 2017$281,0000.0%5,3560.0%0.01%0.0%
Q3 2016$281,0005,3560.01%
Other shareholders
CONMED CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders